Global Cannabidiol Market Forecast to Reach $22.05 Billion by 2030 with 15.8% CAGR

The Rising Cannabidiol Market

The cannabidiol (CBD) market is set for significant growth, with projections indicating a surge to $22.05 billion by the year 2030. This expansion, highlighted in a recent study by Grand View Research, forecasts an impressive compound annual growth rate (CAGR) of 15.8% from 2025 to 2030. Factors contributing to this positive outlook include changing consumer attitudes towards CBD products, an evolving public perception regarding cannabis, and an increasing recognition of the numerous health benefits associated with cannabidiol.

CBD is primarily derived from the cannabis Sativa plant, known for containing over 80 different cannabinoids, among which cannabidiol is leading in medical utilization due to its non-psychoactive properties. Hemp, with its high CBD content, serves as the principal source of this compound, underlining its importance in the market.

The demand for CBD-infused products is diverse, encompassing a range of items like beauty products, oils, beverages, gummies, and capsules, each catering to different consumer needs. CBD's multiple modes of delivery further enhance its accessibility, allowing for ingestion through vaping, smoking, or topical application.

In the U.S., where cannabis legalization has paved the way for commercial growth, CBD is increasingly being incorporated into personal care products and pharmaceuticals. The legalization trend surrounding cannabis-based products not only bolsters the market but also provides substantial opportunities for various industries to enhance their product offerings.

Expanding Market Dynamics

Industry players are heavily focused on introducing innovative CBD-infused products in response to rising demand. Many companies are now exploring opportunities in international markets, reflecting the global expansion of CBD interest. Investment in research and development is becoming a significant strategy among these entities as they strive to produce more effective and efficient products while diversifying their product lines.

Noteworthy Industry Developments

An illustrative example of this development can be found with Medical Marijuana, Inc., which in May 2022, launched a subsidiary in Brazil named HM Pharma to broaden access to CBD products in pharmacies. This reflects a trend where brands are increasingly catering to new and emerging markets.

Market Composition

The North American region dominates the CBD market, accounting for a staggering 86.7% market share in 2024. This is primarily fueled by major manufacturers and the favorable conditions established by the U.S. Farm Bill. Furthermore, hemp-derived CBD is projected to maintain its predominance in the market due to its higher purity levels and recognized health advantages.

Statistical insights reveal that the B2B segment comprises the largest share within the market thanks to the climbing demand and a growing number of businesses incorporating cannabidiol as a key ingredient in their products. The pharmaceuticals sector stands out in terms of end-use market share, driven by the escalating utilization of cannabis derivatives to address various medical conditions.

In summary, the future of the cannabidiol market appears bright and is marked by innovation, increased consumer acceptance, and expansive growth potential across multiple sectors. Whether it is through medical applications or wellness products, CBD continues to establish itself as a vital component in the evolving landscape of health and wellness products.